source
- Acting FDA commissioner reports strong public interest in new expedited IND pilotActing FDA Commissioner Kyle Diamantas told attendees at the Friends of Cancer Research annual meeting that the agency’s newly launched Expedited IND pilot has attracted considerable public attenti…
- Democrats demand unredacted drug pricing agreements from pharma firms after midterm victoriesCongressional Democrats have intensified scrutiny of pharmaceutical pricing agreements made under the previous administration. On Monday they sent letters to every drug maker that entered a most f…